Remove terms
article thumbnail

EMA pins lack of long-term data as rationale for Novartis’ failed Vijoice bid

Pharmaceutical Technology

The EMA raised concerns about the lack of long-term data for Novartis Vijoice in its initial bid, as the Swiss company prepares for a new regulatory submission.

246
246
article thumbnail

Eagle Pharmaceuticals gets grant for long-term stable bendamustine-containing composition in sterile vial

Pharmaceutical Technology

Discover Eagle Pharmaceuticals Inc's patented stable bendamustine-containing composition for long-term storage. Learn about the sterile vial with antioxidants ensuring impurities less than 5% after 15 months.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

BioSenic and Phebra switch up terms of licensing agreement

Pharmaceutical Technology

The updated binding term sheet for an oral arsenic trioxide therapy sees Phebra take on more duties and BioSenic given royalties.

Licensing 130
article thumbnail

Bill C-47 introduces patent term adjustment: Proposed term to run concurrently with term of Certificate of Supplementary Protection

Pharma in Brief

On April 20, 2023, the federal government tabled legislation ( Bill C-47 ) that would amend the Patent Act to bring, for the first time, a system of general patent term adjustment ( PTA ) into Canada. The proposed amendments also suggest that additional maintenance fees will be charged during the PTA term. to 46.4.

article thumbnail

Understanding Patent Term Extensions: An Overview

Drug Patent Watch

The post Understanding Patent Term Extensions: An Overview appeared first on DrugPatentWatch - Make Better Decisions. In the world of patents, the right to exclude others from using or selling an invention is granted only during the patent’s validity. Once a patent expires, this exclusivity vanishes.…

111
111
article thumbnail

CPhI Annual Report 2021: Short term reshoring the catalyst for longer term manufacturing innovations by 2030

Pharma Mirror

In terms of geographic dominance, value in the pharma market will be led by the USA and China [accounting for around 50%], followed by European nations and Japan, with emerging economies still nurturing new R&D centres. These new findings are released ahead of CPhI Worldwide (November 9-11, 2021), which is being held.

article thumbnail

CDMO: Indena’s Long-Term Vision

Pharmaceutical Technology

Indena CDMO origin: Founded in 1921 by Carlo Boccaccio Inverni and Biagio Alberto Della Beffa and headquartered in Milan, Indena…

130
130